Management of mycosis fungoides: Part 1. Diagnosis, Staging, and Prognosis

ONCOLOGY

Volumn 17, Issue 9, 2003, Pages 1281-1288

  Smith, Benjamin D ^a   Wilson, Lynn D ^b  

^a Therapeutic Radiology

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

CANCER STAGING; CD4+ T LYMPHOCYTE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOPHENOTYPING; METABOLISM; MYCOSIS FUNGOIDES; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SEZARY SYNDROME; SKIN TUMOR; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; UNITED STATES;

CD4-POSITIVE T-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL; MYCOSIS FUNGOIDES; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; SEZARY SYNDROME; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS; UNITED STATES;

EID: 1542577502     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Alibert JLM: Tableau du Pian Fungoide Description des Maladies de la Peau, Observees a I'Hopiial Saint-Louis et Exposition des meilleurs Methodes Suivies pour leur Traitement, pp 413-446. Paris, Barrois L'Aine & Fils, 1806.
2. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371, 1997.
3. Zackheim HS, Vonderheid EC, Ramsay DL, et al: Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 43:793-796, 2000.
4. Weinstock MA, Horm JW: Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 260:4246, 1988.
5. Weinstock MA, Gardstein B: Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 89:1240-1244, 1999.
6. Weinstock MA, Reynes JF: The changing survival of patients with mycosis fungoides: A population-based assessment of trends in the United States. Cancer 85:208-212, 1999.
7. Jones GW, Wilson LD: The changing, survival of patients with mycosis fungoides: A population-based assessment of trends in the United States. Cancer 86:191-193, 1999.
8. Morales Suarez-Varela MM, Llopis Gonzalez A, Marquina Vila A, et al: Mycosis fungoides: Review of epidemiological observations. Dermatology 201:21-28, 2000.
9. Zackheim HS, McCalmont TH: Mycosis fungoides: The great imitator. J Am Acad Dermatol 47:914-918, 2002.
10. 10.O'Quinn R P, Zic JA, Boyd AS: Mycosis fungoides d'emblee: CD30-negative cutaneous large T-cell lymphoma. J Am Acad Dermatol 43:861-863, 2000.
11. Glusac EJ: Of cells and architecture: new approaches to old criteria in mycosis fungoides. J Cutan Pathol 28:169-173, 2001.
12. Santucci M, Biggeri A, Feller AC, et al: Efficacy of histologic criteria for diagnosing early mycosis fungoides: An EORTC cutaneous lymphoma study group investigation. Am J Surg Pathol 24:40-50, 2000.
13. Smoller BR, Bishop K, Glusac E, et al: Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 19:1423-1430, 1995.
14. Cribier BJ: The myth of Pautrier's microabscesses. J Am Acad Dermatol 48:796-797, 2003.
15. Guitart J, Kennedy J, Ronan S, et al: Histologic criteria for the diagnosis of mycosis fungoides: Proposal for a grading system to standardize pathology reporting. J Cutan Pathol 28:174-183, 2001.
16. Kohler S, Kim YH, Smoller BR: Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sezary syndrome: A critical reappraisal. J Cutan Pathol 24:292-297, 1997.
17. Fung MA, Murphy MI, Hoss DM, et al: Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 46:325-357, 2002.
18. Ormsby A, Bergfeld WF, Tubbs RR, et al: Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: Implications for diagnosis of mycosis fungoides in community clinical practice. J Am Acad Dermatol 45:405413, 2001.
19. Delfau-Larue MH, Laroche L, Wechsler J, et al: Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 96:2987-2992, 2000.
20. Wood GS, Tung RM, Haeffner AC, et al: Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103:3441, 1994.
21. Ashton-Key M, Diss TC, Du MQ, et al: The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates. Am J Surg Pathol 21:743-747, 1997.
22. Dadej K, Gaboury L, Lamarre L, et al: The value of clonality in the diagnosis and follow-up of patients with cutaneous T-cell infiltrates. Diagn Mol Pathol 10:78-88, 2001.
23. Bass JC, Korobkin MT, Cooper KD, et al: Cutaneous T-cell lymphoma: CT in evaluation and staging. Radiology 186:273-278, 1993.
24. Sibaud V, Beylot-Barry M, Thiebaut R, et al: Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas. Am J Clin Pathol 119:414-423, 2003.
25. Graham SJ, Sharpe RW, Steinberg SM, et al: Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sezary syndrome. Cancer 72:726-734, 1993.
26. Diamandidou E, Colome M, Fayad L, et al: Prognostic factor analysis in mycosis fun-goides/Sezary syndrome. J Am Acad Dermatol 40:914-924, 1999.
27. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Handbook, 6th ed. New York, Springer, 2002.
28. Kim YH, Martinez G, Varghese A, et al: Topical nitrogen mustard in the management of mycosis fungoides: Update of the Stanford experience. Arch Dermatol 139:165-173, 2003.
29. Kashani-Sabet M, McMillan A, Zackheim HS: A modified staging classification for cutaneous T-cell lymphoma. J Am Acad Dermatol 45:700-706, 2001.
30. de Coninck EC, Kim YH, Varghese A, et al: Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. J Clin Oncol 19:779-784, 2001.
31. Kim YH, Hoppe RT: Mycosis fungoides and the Sezary syndrome. Semin Oncol 26:276-289, 1999.
32. Vonderheid EC, Diamond LW, van Vlo-ten WA, et al: Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage. Cancer 73:207-218, 1994.
33. Hoppe RT, Medeiros LJ, Warnke RA, et al: CD8-positive rumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448453, 1995.
34. Delfau-Larue MH, Dalac S, Lepage E, et al: Prognostic significance of a polymerase chain reaction-detectable dominant T-Iymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 92:3376-3380, 1998.
35. Guitart J, Camisa C, Ehrlich M, et al: Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma. J Am Acad Dermatol 48:775-779, 2003.
36. Beylot-Barry M, Sibaud V, Thiebaut R, et al: Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol 117:920-926, 2001.
37. Bakels V, Van Oostveen JW, Geerts ML, et al: Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides. J Pathol 170:249-255, 1993.
38. Kim YH, Bishop K, Varghese A, et al: Prognostic factors in erythrodermic mycosis-fungoides and the Sezary syndrome. Arch Dermatol 131:1003-1008, 1995.
39. Vonderheid EC, Bemengo MG, Burg G, et al: Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95-106, 2002.
40. Diamandidou E, Colome-Grimmer M, Fayad L, et al: Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis. Blood 92:1150-1159, 1998.
41. Vergier B, de Muret A, Beylot-Barry M, et al: Transformation of mycosis fungoides: Clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 95:2212-2218, 2000.